METHOD FOR PREVENTION AND / OR TREATMENT OF FIBROSIS AND / OR REMOVAL OF THE CORNETAL (OPTIONS), METHOD FOR PRODUCING A PHARMACEUTICAL COMPOSITION FOR PREVENTION AND / OR TREATMENT OF FIBROSIS AND / OR REMOVAL PRACTICE

摘要

1. The use of a peptide that inhibits TGF-β1 and is characterized by the amino acid sequence of SEQ ID NO: 6, for the prevention and / or treatment of corneal fibrosis and / or corneal opacity. The use of a peptide that inhibits TGF-β1 and is characterized by the amino acid sequence of SEQ ID NO: 6, in the manufacture of a pharmaceutical composition for the prevention and / or treatment of corneal fibrosis and / or corneal opacity. 3. A method for the prevention and / or treatment of corneal fibrosis and / or corneal clouding, comprising administering to a subject in need of treatment a therapeutically effective amount of a TGF-β1 inhibiting peptide and characterized by the amino acid sequence of SEQ ID NO: 6.4. An ophthalmic pharmaceutical composition comprising a therapeutically effective amount of a peptide that inhibits TGF-β1 and characterized by the amino acid sequence of SEQ ID NO: 6, and a pharmaceutically acceptable carrier suitable for ophthalmic administration, and made in the form of a local pharmaceutical composition containing hyaluronic acid or a pharmaceutically acceptable salt thereof .